1928 offers a cloud-based bioinformatics platform that processes raw sequencing data using customized algorithms to deliver actionable insights on antibiotic resistance. This technology enables microbiologists to efficiently analyze pathogen DNA, facilitating informed treatment decisions and enhancing infection control efforts.
Funding
Funding not disclosed
Founders
Product
Problem
Microbiologists face challenges in efficiently analyzing pathogen DNA from raw sequencing data to gain actionable insights on antibiotic resistance. Traditional bioinformatics analysis can be complex, time-consuming, and require specialized expertise, hindering informed treatment decisions and effective infection control efforts.
Solution
The 1928 platform is a cloud-based bioinformatics solution designed to streamline the analysis of raw sequencing data, providing microbiologists with actionable insights into antibiotic resistance. The platform utilizes customized, well-validated algorithms to process raw data files from sequencing machines, converting DNA reads into high-resolution information on pathogen DNA. By optimizing data handling in the cloud, the platform ensures efficient and rapid calculations through optimized workflows and distributed systems. The platform delivers decision support for treatment and surveillance, enabling users to make informed decisions.
Target Audience
The primary users are microbiologists in hospitals and research institutions who need to analyze sequencing data for antibiotic resistance and infection control.
Features
- Cloud-based platform accessible through a web service
- Customized algorithms for processing raw sequencing data
- Resistance and typing database for matching sequence data
- Analysis of pathogen DNA for antibiotic resistance markers
- Decision support for treatment and surveillance
- User account management with hospital organization configuration
- Active monitoring by the 1928 team to ensure complete and relevant analysis